Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemangioendothelial sarcoma of bone

L E Wold, K K Unni, J W Beabout

    The American Journal of Surgical Pathology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pigmented villonodular synovitis.

    Orthopedics·2014
    Same author

    Synovial sarcoma.

    Orthopedics·2014
    Same author

    Mayo clinic tumor rounds.

    Orthopedics·2014
    Same author

    Malignant giant cell tumor of bone.

    Orthopedics·2014
    Same author

    Adamantinoma.

    Orthopedics·2014
    Same author

    Fluoroscopically positioned radiographs of total shoulder arthroplasty.

    Journal of shoulder and elbow surgery·2012

    Histologic grade is the key prognostic factor for bone hemangioendothelial sarcoma, a rare bone tumor. This study of 112 cases found grade, not tumor multiplicity, predicts survival, with surgery as the main treatment.

    Area of Science:

    • Orthopedic Oncology
    • Bone Tumors
    • Surgical Pathology

    Background:

    • Hemangioendothelial sarcoma of bone is an exceptionally rare malignant neoplasm.
    • Understanding its clinical and pathological characteristics is crucial for effective management.

    Purpose of the Study:

    • To define the clinical and pathological features of bone hemangioendothelial sarcoma.
    • To identify prognostic indicators for disease-free survival in patients with this rare bone tumor.

    Main Methods:

    • Retrospective analysis of 112 cases of bone hemangioendothelial sarcoma.
    • Evaluation of various histologic features to determine prognostic significance.
    • Correlation of histologic grade with disease-free survival.

    Main Results:

    Related Experiment Videos

    • Histologic grade was the single most significant prognostic factor correlating with disease-free survival.
    • Multifocal tumors did not confer a worse prognosis compared to unicentric disease.
    • Surgery is the primary therapeutic modality.

    Conclusions:

    • Histologic grade is a critical prognostic marker for bone hemangioendothelial sarcoma.
    • Surgical intervention is the mainstay of treatment.
    • Radiotherapy may benefit patients with surgically inaccessible axial skeletal lesions, while chemotherapy's role remains undetermined.